Sensory Stimulation for Alzheimer's Disease (Hope Trial)

"This medical trial is open to 345 individuals between 50 and 85 years of age who have been diagnosed with Alzheimer's disease. Furthermore, they must be able to pass the Mini-Mental State Exam (MMSE) 15-26, demonstrate non-childbearing potential if biologically female or abstain from sexual activity if male with a childbearing partner; possess formal education of 8+ years; show adequate vision and hearing capacity; display mobility capability for compliance with testing procedures (e.g., ambulatory or aided-ambulatory); exhibit stable chronic conditions in the last 30 days; identify an appropriate Legally Authorized Representative (LAR),"

"As indicated by clinicaltrials.gov, this investigation is not presently looking for participants. Posted on December 1st of 2022 and recently modified on the same day, it does not appear that any new applicants are being accepted at this time; however, 1207 other trials are recruiting patients now."

"The primary target of this clinical trial, monitored over the duration of a 12-month period, is to assess and evaluate changes in Alzheimer's disease Cooperative Study - Activities of Daily Living (ADCS-ADL). Secondary objectives include tracking modifications from Baseline in Hippocampal volume through 3T Magnetic Resonance Imaging (MRI), Clinical Dementia Rating- Sum of Boxes (CDR-SB) for global symptom change, and Mini Mental State Exam (MMSE) for cognitive progression."

"This trial's enrollment requirements state that the minimum age for participants is 50, while the highest allowable age is 85."

"At this time, 10 clinical trial sites across the country are seeking patients for participation. These locations include Brooklyn, Stuart and Winter Park as well as seven other areas; selecting a clinic closest to you can reduce your travel needs if you choose to join the study."